Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application, Transplant Type - Forecast to 2025

  • ID: 3971860
  • Report
  • Region: Global
  • 158 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Cesca Therapeutics Inc.
  • Escape Therapeutics
  • Kiadis
  • Lonza Group
  • PromoCell GmbH
  • Regen Biopharma, Inc
  • MORE

"Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application (Solid Tumors, Leukemia, Non-malignant Disorders and Lymphoproliferative Disorders), Transplant Type (Allogeneic Transplant and Autologous Transplant) - Forecast to 2025"

The Global Hematopoietic Stem Cell Transplantation Market is poised to grow at a CAGR of around 11.4% over the next decade to reach approximately $10.9 billion by 2025. Some of the prominent trends that the market is witnessing include technological advancements in regenerative stromal cell therapy, development of transplantation activity across the globe, recent technological developments of Hematopoietic Stem Cell Transplantation and growth opportunities/investment opportunities.

Based on application the market is categorized into solid tumors, leukemia, non-malignant disorders and lymphoproliferative disorders. Depending on the transplant type the market is segmented by allogeneic transplant and autologous transplant.

This industry report analyzes the global markets for Hematopoietic Stem Cell Transplantation across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Hematopoietic Stem Cell Transplantation Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • Africa
  • Caribbean

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cesca Therapeutics Inc.
  • Escape Therapeutics
  • Kiadis
  • Lonza Group
  • PromoCell GmbH
  • Regen Biopharma, Inc
  • MORE

1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Technological Advancements in Regenerative Stromal Cell Therapy
3.1.2 Development of Transplantation Activity Across The Globe
3.1.3 Recent Technological Developments of Hematopoietic Stem Cell Transplantation
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Hematopoietic Stem Cell Transplantation Market, By Application
4.1 Solid Tumors
4.1.1 Solid Tumors Market Forecast to 2025 (US$ MN)
4.2 Leukemia
4.2.1 Leukemia Market Forecast to 2025 (US$ MN)
4.3 Non-malignant Disorders
4.3.1 Non-malignant Disorders Market Forecast to 2025 (US$ MN)
4.4 Lymphoproliferative Disorders
4.4.1 Lymphoproliferative Disorders Market Forecast to 2025 (US$ MN)

5 Hematopoietic Stem Cell Transplantation Market, By Transplant Type
5.1 Allogeneic Transplant
5.1.1 Allogeneic Transplant Market Forecast to 2025 (US$ MN)
5.2 Autologous Transplant
5.2.1 Autologous Transplant Market Forecast to 2025 (US$ MN)

6 Hematopoietic Stem Cell Transplantation Market, By Geography
6.1 North America
6.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
6.1.1.1 US
6.1.1.2 Canada
6.1.1.3 Mexico
6.2 Europe
6.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
6.2.1.1 France
6.2.1.2 Germany
6.2.1.3 Italy
6.2.1.4 Spain
6.2.1.5 U.K.
6.2.1.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
6.3.1.1 Japan
6.3.1.2 China
6.3.1.3 India
6.3.1.4 Australia
6.3.1.5 New Zealand
6.3.1.6 Rest of APAC
6.4 Middle East
6.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
6.4.1.1 Saudi Arabia
6.4.1.2 UAE
6.4.1.3 Rest of Middle East

6.5 Latin America
6.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
6.5.1.1 Argentina
6.5.1.2 Brazil
6.5.1.3 Rest of Latin America
6.6 Rest of the World (RoW)
6.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
6.6.1.1 Africa
6.6.1.2 Caribbean

7 Key Player Activities
7.1 Mergers & Acquisitions
7.2 Partnerships, Joint Venture’s, Collaborations and Agreements
7.3 Product Launch & Expansions
7.4 Other Activities

8 Leading Companies
8.1 Lonza Group
8.2 Stempuetics Research Pvt. Ltd.
8.3 ScienCell Research Laboratories
8.4 Thermo Fisher Scientific, Inc.
8.5 Escape Therapeutics
8.6 PromoCell GmbH
8.8 TiGenix N.V.
8.8 R&D Systems
8.9 Cesca Therapeutics Inc.
8.10 CellGenix Technologie Transfer GmbH
8.11 Pluristem Therapeutics Inc.
8.12 Kite Pharma Inc.
8.13 Takara Bio
8.14 Genlantis
8.15 Actinium Pharmaceuticals, Inc.
8.16 Targazyme, Inc.
8.18 Novartis AG
8.19 Regen Biopharma, Inc
8.20 Cryo-Save AG
8.21 China Cord Blood Corporation.
8.22 Kiadis

List of Tables
Table 1 Global Hematopoietic Stem Cell Transplantation Market By Region, Market Forecast (2013-2025) (US$ MN)
Table 2 Global Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 3 Global Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 4 Global Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 5 Global Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 6 Global Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 7 Global Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 8 Global Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 9 Global Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 10 North America Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 11 North America Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 12 North America Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 13 North America Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 14 North America Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 15 North America Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 16 North America Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 17 North America Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 18 North America Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 19 Europe Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 20 Europe Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 21 Europe Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 22 Europe Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 23 Europe Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 24 Europe Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 25 Europe Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 26 Europe Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 27 Europe Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 28 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 29 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 30 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 31 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 32 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 33 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 34 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 35 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 36 Asia Pacific Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 37 Middle East Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 38 Middle East Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 39 Middle East Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 40 Middle East Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 41 Middle East Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 42 Middle East Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 43 Middle East Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 44 Middle East Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 45 Middle East Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 46 Latin America Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 47 Latin America Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 48 Latin America Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 49 Latin America Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 50 Latin America Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 51 Latin America Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 52 Latin America Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 53 Latin America Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 54 Latin America Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)
Table 55 RoW Hematopoietic Stem Cell Transplantation Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 56 RoW Hematopoietic Stem Cell Transplantation Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 57 RoW Hematopoietic Stem Cell Transplantation Market By Solid Tumors, Market Forecast (2013-2025) (US$ MN)
Table 58 RoW Hematopoietic Stem Cell Transplantation Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 59 RoW Hematopoietic Stem Cell Transplantation Market By Non-malignant Disorders, Market Forecast (2013-2025) (US$ MN)
Table 60 RoW Hematopoietic Stem Cell Transplantation Market By Lymphoproliferative Disorders, Market Forecast (2013-2025) (US$ MN)
Table 61 RoW Hematopoietic Stem Cell Transplantation Market By Transplant Type, Market Forecast (2013-2025) (US$ MN)
Table 62 RoW Hematopoietic Stem Cell Transplantation Market By Allogeneic Transplant, Market Forecast (2013-2025) (US$ MN)
Table 63 RoW Hematopoietic Stem Cell Transplantation Market By Autologous Transplant, Market Forecast (2013-2025) (US$ MN)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Actinium Pharmaceuticals, Inc.
  • CellGenix Technologie Transfer GmbH
  • Cesca Therapeutics Inc.
  • China Cord Blood Corporation.
  • Cryo-Save AG
  • Escape Therapeutics
  • Genlantis
  • Kiadis
  • Kite Pharma Inc.
  • Lonza Group
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • PromoCell GmbH
  • R&D Systems
  • Regen Biopharma, Inc
  • ScienCell Research Laboratories
  • Stempuetics Research Pvt. Ltd.
  • Takara Bio
  • Targazyme, Inc.
  • Thermo Fisher Scientific, Inc.
  • TiGenix N.V.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll